Ellington Financial Upgraded to Overweight Rating
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Source: Yahoo Finance
- Rating Upgrade: Ellington Financial (EFC) has received an upgrade to an overweight rating, indicating analysts' optimistic outlook on its future performance, which may attract more investor interest.
- Price Target Set: The average price target is set at $14.79, reflecting a positive market sentiment towards the company's future stock price, potentially driving the stock closer to this target.
- Market Reaction: The rating upgrade could lead to a short-term increase in stock price, boosting investor confidence and enhancing the company's performance in the capital markets.
- Investment Appeal: With the rating elevation, Ellington Financial may attract more institutional investors, further strengthening its market position and liquidity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EFC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EFC
Wall Street analysts forecast EFC stock price to rise
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 13.420
Low
14.50
Averages
15.00
High
16.00
Current: 13.420
Low
14.50
Averages
15.00
High
16.00
About EFC
Ellington Financial Inc. operates as a real estate investment trust (REIT). The Company acquires and manages mortgage-related, consumer-related, corporate-related, and other financial assets. Its segments include Investment Portfolio Segment and Longbridge Segment. The Investment Portfolio Segment invests in financial assets, including residential and commercial mortgage loans; residential mortgage-backed securities (RMBS); commercial mortgage-backed securities (CMBS); consumer loans and asset-backed securities (ABS) including ABS backed by consumer loans; investments referencing mortgage servicing rights on traditional forward mortgage loans; collateralized loan obligations; non-mortgage- and mortgage-related derivatives; debt and equity investments in loan origination companies; and other strategic investments. The Longbridge Segment is engaged in the business of originating, purchasing, selling and servicing reverse mortgage loans, including home equity conversion mortgage loans.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ellington Financial Upgraded to Overweight Rating
- Rating Upgrade: Ellington Financial (EFC) has received an upgrade to an overweight rating, indicating analysts' optimistic outlook on its future performance, which may attract more investor interest.
- Price Target Set: The average price target is set at $14.79, reflecting a positive market sentiment towards the company's future stock price, potentially driving the stock closer to this target.
- Market Reaction: The rating upgrade could lead to a short-term increase in stock price, boosting investor confidence and enhancing the company's performance in the capital markets.
- Investment Appeal: With the rating elevation, Ellington Financial may attract more institutional investors, further strengthening its market position and liquidity.
See More
Ellington Financial's Preferred Stock Dividend History
- Dividend History Overview: Ellington Financial Inc's 7.00% Series B Cumulative Perpetual Redeemable Preferred Stock recently declared a dividend of $0.4375 per share, indicating the company's commitment to shareholder returns and enhancing investor confidence.
- ETF Composition Ratio: According to ETF Finder, Ellington Financial Inc constitutes 4.67% of the Vaneck Mortgage REIT Income ETF (MORT), highlighting its significance in related investment portfolios and potentially attracting more institutional investor interest.
- Stock Performance: In Tuesday trading, Ellington Financial Inc's preferred shares rose approximately 0.4%, while common shares increased by about 0.6%, reflecting positive market sentiment towards the company's stock, which may drive future investment inflows.
- Market Dynamics: The MORT ETF increased by about 1.1% on the day, indicating strong performance in the overall REIT market, which could provide a favorable environment for Ellington Financial to achieve growth.
See More
Ellington Financial Declares Dividend Payments
- Monthly Dividend Announcement: Ellington Financial has declared a monthly dividend of $0.13 per share, payable on July 31, 2026, to common stockholders of record as of June 30, 2026, demonstrating the company's ongoing commitment to shareholder returns.
- Preferred Stock Dividend Plan: The company will pay a quarterly dividend of $0.390625 per share on its 6.250% Series B Preferred Stock on July 30, 2026, to Series B preferred stockholders of record as of June 30, 2026, indicating stability among preferred investors.
- Diverse Dividend Structure: Ellington Financial will also distribute a quarterly dividend of $0.5390625 per share to Series C preferred stockholders and $0.4375 per share to Series D preferred stockholders, reflecting the company's financial health across different shareholder groups.
- Forward-Looking Statement Risks: The announcement includes caution regarding forward-looking statements, highlighting potential risks and uncertainties that could affect future performance, emphasizing sensitivity to market volatility and interest rate changes, and advising investors to carefully assess future investment decisions.
See More
Clover Health Reports Poor Quarterly Performance
- Quarterly Performance Analysis: Clover Health Investments reported a disappointing quarter, with revenues being acceptable but earnings falling short of expectations, indicating uncertainty in the company's market position and advising investors to approach stock price fluctuations with caution.
- Market Reaction Observation: Despite a rise in Clover Health's stock price, analysts caution that this increase may be speculative, as the fundamentals have not improved, reflecting concerns about the company's future development in the market.
- Industry Comparison: Compared to other firms, Clover Health's profitability is weaker, particularly in the healthcare investment sector, which may lead to a decline in investor confidence regarding its long-term growth potential.
- Investment Recommendations: Analysts maintain a cautious stance on investing in Clover Health, suggesting that in the absence of clear profit guidance, investors should consider other more stable investment options.
See More
Delphi Financial Increases Stake in Ellington Financial
- Increased Stake: Delphi Financial acquired an additional 686,639 shares of Ellington Financial in Q1 2026, with an estimated transaction value of $8.73 million, demonstrating confidence in Ellington's future prospects and solidifying its position in the portfolio.
- Asset Management Proportion Rise: Following the increase, Ellington Financial now represents 7.53% of Delphi's 13F reportable AUM, indicating its sixth position in Delphi's investment portfolio and highlighting its significance in diversified investment strategies.
- Strong Financial Performance: Ellington Financial achieved record earnings in Q1 2026, with a net income of $146.87 million, indicating robust business fundamentals that continue to attract Delphi Financial's investment.
- Stable Dividend Payments: Ellington Financial has reliably issued monthly dividends since 2010, providing a stable cash flow that adds to the attractiveness of Delphi's increased stake, although investors must still consider risks related to interest rates and economic fluctuations.
See More
Delphi Increases Stake in Ellington Financial by $8.73 Million
- Increased Stake: Delphi Financial Group increased its stake in Ellington Financial by 686,639 shares in Q1 2026, with an estimated transaction value of $8.73 million, indicating strong confidence in Ellington's future prospects.
- Asset Allocation Shift: This acquisition raises Ellington Financial's representation in Delphi's 13F reportable AUM to 7.53%, moving it to the sixth-largest holding, reflecting its significance in a diversified investment portfolio.
- Strong Financial Performance: Ellington Financial reported record earnings in Q1 2026 with a net income of $146.87 million, demonstrating robust business fundamentals that continue to attract Delphi's investment.
- Stable Dividend Payments: Having issued monthly dividends since 2010, Ellington Financial's reliable cash flow adds extra appeal for Delphi's increased stake, although investors must still consider risks related to interest rates and economic fluctuations.
See More
Ellington Financial Upgraded to Overweight Rating
- Rating Upgrade: Ellington Financial (EFC) has received an upgrade to an overweight rating, indicating analysts' optimistic outlook on its future performance, which may attract more investor interest.
- Price Target Set: The average price target is set at $14.79, reflecting a positive market sentiment towards the company's future stock price, potentially driving the stock closer to this target.
- Market Reaction: The rating upgrade could lead to a short-term increase in stock price, boosting investor confidence and enhancing the company's performance in the capital markets.
- Investment Appeal: With the rating elevation, Ellington Financial may attract more institutional investors, further strengthening its market position and liquidity.
See More
Ellington Financial's Preferred Stock Dividend History
- Dividend History Overview: Ellington Financial Inc's 7.00% Series B Cumulative Perpetual Redeemable Preferred Stock recently declared a dividend of $0.4375 per share, indicating the company's commitment to shareholder returns and enhancing investor confidence.
- ETF Composition Ratio: According to ETF Finder, Ellington Financial Inc constitutes 4.67% of the Vaneck Mortgage REIT Income ETF (MORT), highlighting its significance in related investment portfolios and potentially attracting more institutional investor interest.
- Stock Performance: In Tuesday trading, Ellington Financial Inc's preferred shares rose approximately 0.4%, while common shares increased by about 0.6%, reflecting positive market sentiment towards the company's stock, which may drive future investment inflows.
- Market Dynamics: The MORT ETF increased by about 1.1% on the day, indicating strong performance in the overall REIT market, which could provide a favorable environment for Ellington Financial to achieve growth.
See More
Ellington Financial Declares Dividend Payments
- Monthly Dividend Announcement: Ellington Financial has declared a monthly dividend of $0.13 per share, payable on July 31, 2026, to common stockholders of record as of June 30, 2026, demonstrating the company's ongoing commitment to shareholder returns.
- Preferred Stock Dividend Plan: The company will pay a quarterly dividend of $0.390625 per share on its 6.250% Series B Preferred Stock on July 30, 2026, to Series B preferred stockholders of record as of June 30, 2026, indicating stability among preferred investors.
- Diverse Dividend Structure: Ellington Financial will also distribute a quarterly dividend of $0.5390625 per share to Series C preferred stockholders and $0.4375 per share to Series D preferred stockholders, reflecting the company's financial health across different shareholder groups.
- Forward-Looking Statement Risks: The announcement includes caution regarding forward-looking statements, highlighting potential risks and uncertainties that could affect future performance, emphasizing sensitivity to market volatility and interest rate changes, and advising investors to carefully assess future investment decisions.
See More
Clover Health Reports Poor Quarterly Performance
- Quarterly Performance Analysis: Clover Health Investments reported a disappointing quarter, with revenues being acceptable but earnings falling short of expectations, indicating uncertainty in the company's market position and advising investors to approach stock price fluctuations with caution.
- Market Reaction Observation: Despite a rise in Clover Health's stock price, analysts caution that this increase may be speculative, as the fundamentals have not improved, reflecting concerns about the company's future development in the market.
- Industry Comparison: Compared to other firms, Clover Health's profitability is weaker, particularly in the healthcare investment sector, which may lead to a decline in investor confidence regarding its long-term growth potential.
- Investment Recommendations: Analysts maintain a cautious stance on investing in Clover Health, suggesting that in the absence of clear profit guidance, investors should consider other more stable investment options.
See More
Delphi Financial Increases Stake in Ellington Financial
- Increased Stake: Delphi Financial acquired an additional 686,639 shares of Ellington Financial in Q1 2026, with an estimated transaction value of $8.73 million, demonstrating confidence in Ellington's future prospects and solidifying its position in the portfolio.
- Asset Management Proportion Rise: Following the increase, Ellington Financial now represents 7.53% of Delphi's 13F reportable AUM, indicating its sixth position in Delphi's investment portfolio and highlighting its significance in diversified investment strategies.
- Strong Financial Performance: Ellington Financial achieved record earnings in Q1 2026, with a net income of $146.87 million, indicating robust business fundamentals that continue to attract Delphi Financial's investment.
- Stable Dividend Payments: Ellington Financial has reliably issued monthly dividends since 2010, providing a stable cash flow that adds to the attractiveness of Delphi's increased stake, although investors must still consider risks related to interest rates and economic fluctuations.
See More
Delphi Increases Stake in Ellington Financial by $8.73 Million
- Increased Stake: Delphi Financial Group increased its stake in Ellington Financial by 686,639 shares in Q1 2026, with an estimated transaction value of $8.73 million, indicating strong confidence in Ellington's future prospects.
- Asset Allocation Shift: This acquisition raises Ellington Financial's representation in Delphi's 13F reportable AUM to 7.53%, moving it to the sixth-largest holding, reflecting its significance in a diversified investment portfolio.
- Strong Financial Performance: Ellington Financial reported record earnings in Q1 2026 with a net income of $146.87 million, demonstrating robust business fundamentals that continue to attract Delphi's investment.
- Stable Dividend Payments: Having issued monthly dividends since 2010, Ellington Financial's reliable cash flow adds extra appeal for Delphi's increased stake, although investors must still consider risks related to interest rates and economic fluctuations.
See More
